These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 14645406)
1. Therapeutic strategies in gastric cancer. Wong JE; Ito Y; Correa P; Peeters KC; van de Velde CJ; Sasako M; Macdonald J J Clin Oncol; 2003 Dec; 21(23 Suppl):267s-269s. PubMed ID: 14645406 [TBL] [Abstract][Full Text] [Related]
2. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers. Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423 [TBL] [Abstract][Full Text] [Related]
3. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Ito K; Liu Q; Salto-Tellez M; Yano T; Tada K; Ida H; Huang C; Shah N; Inoue M; Rajnakova A; Hiong KC; Peh BK; Han HC; Ito T; Teh M; Yeoh KG; Ito Y Cancer Res; 2005 Sep; 65(17):7743-50. PubMed ID: 16140942 [TBL] [Abstract][Full Text] [Related]
4. Molecular basis of therapeutic approaches to gastric cancer. Wu K; Nie Y; Guo C; Chen Y; Ding J; Fan D J Gastroenterol Hepatol; 2009 Jan; 24(1):37-41. PubMed ID: 19196394 [TBL] [Abstract][Full Text] [Related]
5. Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis. Wei D; Gong W; Oh SC; Li Q; Kim WD; Wang L; Le X; Yao J; Wu TT; Huang S; Xie K Cancer Res; 2005 Jun; 65(11):4809-16. PubMed ID: 15930301 [TBL] [Abstract][Full Text] [Related]
6. Runx3-/- gastric epithelial cells differentiate into intestinal type cells. Fukamachi H; Ito K; Ito Y Biochem Biophys Res Commun; 2004 Aug; 321(1):58-64. PubMed ID: 15358215 [TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer. Kitajima Y; Ohtaka K; Mitsuno M; Tanaka M; Sato S; Nakafusa Y; Miyazaki K Oncol Rep; 2008 Jan; 19(1):197-202. PubMed ID: 18097595 [TBL] [Abstract][Full Text] [Related]
8. Contribution of reactivated RUNX3 to inhibition of gastric cancer cell growth following suberoylanilide hydroxamic acid (vorinostat) treatment. Huang C; Ida H; Ito K; Zhang H; Ito Y Biochem Pharmacol; 2007 Apr; 73(7):990-1000. PubMed ID: 17276407 [TBL] [Abstract][Full Text] [Related]
10. RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer. Peng Z; Wei D; Wang L; Tang H; Zhang J; Le X; Jia Z; Li Q; Xie K Clin Cancer Res; 2006 Nov; 12(21):6386-94. PubMed ID: 17085650 [TBL] [Abstract][Full Text] [Related]
11. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD. Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801 [TBL] [Abstract][Full Text] [Related]
12. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation]. Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692 [TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori causes runx3 gene methylation and its loss of expression in gastric epithelial cells, which is mediated by nitric oxide produced by macrophages. Katayama Y; Takahashi M; Kuwayama H Biochem Biophys Res Commun; 2009 Oct; 388(3):496-500. PubMed ID: 19665002 [TBL] [Abstract][Full Text] [Related]
14. Growth regulation of gastric epithelial cells by Runx3. Fukamachi H; Ito K Oncogene; 2004 May; 23(24):4330-5. PubMed ID: 15156189 [TBL] [Abstract][Full Text] [Related]
15. Resection for gastric cancer in the community. van de Velde CJ Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441 [TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681 [TBL] [Abstract][Full Text] [Related]
17. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584. Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977 [TBL] [Abstract][Full Text] [Related]
18. Loss of RUNX3 expression correlates with differentiation, nodal metastasis, and poor prognosis of gastric cancer. Hsu PI; Hsieh HL; Lee J; Lin LF; Chen HC; Lu PJ; Hsiao M Ann Surg Oncol; 2009 Jun; 16(6):1686-94. PubMed ID: 19290488 [TBL] [Abstract][Full Text] [Related]
19. Lack of RUNX3 regulation in human gastric cancer. Friedrich MJ; Rad R; Langer R; Voland P; Hoefler H; Schmid RM; Prinz C; Gerhard M J Pathol; 2006 Oct; 210(2):141-6. PubMed ID: 16917803 [TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitor trichostatin A induced caspase-independent apoptosis in human gastric cancer cell. Wu ZQ; Zhang R; Chao C; Zhang JF; Zhang YQ Chin Med J (Engl); 2007 Dec; 120(23):2112-8. PubMed ID: 18167185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]